“Aprepitant, a Novel Neurokinin-1 Receptor Antagonist in Management of Chemotherapy Induces Nausea Vomiting (CINV) in Cancer Patients”. 2019. International Journal of Research in Clinical and Hospital Pharmacy 2 (1): 1-4. https://rubatosis.org/journals/index.php/ijrhcp/article/view/144.